Ym90k, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 5, 1998, Pages 586-591

  Kawasaki Yatsugi, Sachiko ^a   Ichiki, Chikako ^a   Yatsugi, Shin Ichi ^a   Shimizu Sasamata, Masao ^a   Yamaguchi, Tokio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Focal cerebral ischemia; YM90K; amino 3 hydroxy 5 methyl 4 isoxazolepropionate (AMPA) receptor

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; RAT; STROKE;

EID: 0031769499     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005297     Document Type: Article

References (29)

1. Belayev L, Alonso OF, Bust R, Zhao W, Ginsberg MD (1996) Middle cerebral artery occlusion in the rat by intraluminal suture: neurological and pathological evaluation of an improved model. Stroke 27:1616-1623
2. Buchan AM, Xue D, Slivka A (1992a) A new model of temporary focal neocortical ischemia in the rat. Stroke 25:153-159
3. Buchan AM, Xue D, Slivka A (1992b) The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 574:171-177
4. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR (1994) Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25:869-876
5. Garcia JH, Wagner S, Liu KF, Hu X (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 26:627-635
6. Gill R (1994) The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/Kainate antagonists and the role in cerebral ischaemia. Cerebrovasc Brain Metab Rev 6:225-256
7. Gill R, Haegeli M (1997) Variability in the size of the penumbra and protection with MK-801 in the suture model of permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 17 [Suppl 1]:S306
8. Ginsberg MD, Busto R (1989) Rodent models of cerebral ischemia. Stroke 20:1627-1642
9. Graham SH, Chen I, Lan JQ, Simon RP (1996) A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. J Pharmacol Exp Ther 276:1-4
10. Iijima T, Mies G, Hossmann KA (1992) Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK801: effect on volume of ischemic injury. J Cereb Blood Flow Metab 12:727-733
11. Izumisawa N, Kawakami A, Ohata T, Hanada T, Okeda R (1995) YM90K, an AMPA antagonist, has no neurotoxic effects on cerebrocortical neurons in rats. Exp Neurol 134:199-204
12. Kawasaki-Yatsugi S, Yatsugi S, Koshiya K, Shimizu-Sasamata M (1997) Neuroprotective effect of YM90K, an AMPA receptor antagonist, against delayed neuronal death induced by transient global ischemia in gerbils and rats. Jpn J Pharmacol 74:253-260
13. Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969-974
14. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G (1986) Experimental studies of ischemic brain edema. I. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 8:1-8
15. Mies G, Kohno K, Hossmann KA (1994) Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J Cereb Blood Flow Metab 14:802-807
16. Minematsu K, Fisher M, Li L, Sotak CH (1993) Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats. Stroke 24:2074-2081
17. Okada M, Hidaka K, Togami J, Ohno K, Tada S, Ohmori J, Sakamoto S, Yamaguchi T (1992) α-Amino-3,5-methylisoxazole-4-propionate (AMPA) excitatory amino acid receptor antagonistic properties of YM900 (6-(1H-Imidazol-1-yl)-7-nitroquinoxaline-2,3(1H,4H)-dione). Soc Neurosci Abstr 18:87
18. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515-1518
19. Sheardown MJ, Nielsen EØ, Hansen AJ, Jacobsen P, Honore T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline: a neuroprotectant for cerebral ischemia. Science 247:571-574
20. Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K (1996) YM90K: pharmacological characterization as a selective and potent α-amino-3,5-methylisoxazole-4-propionate (AMPA)/Kainate receptor antagonist. J Pharmacol Exp Ther 276:84-92
21. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293
22. Takizawa S, Hogan M, Hakim AM (1991) The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 11:786-793
23. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981) Focal cerebral ischemia in the rat: description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60
24. Umemura K, Shimakura A, Nakashima M (1997) Neuroprotective effect of a novel AMPA antagonist. YM90K, in rat focal cerebral ischemia. Brain Res 77:361-365
25. Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE, Buchan AM (1994) Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab 14:251-261
26. Yao H, Ginsberg MD, Watson BD, Prado R, Dietrich WD, Kraydieh S, Bust R (1993) Failure of MK-801 to reduce infarct volume in thrombotic middle cerebral artery occlusion in rats. Stroke 24:864-871
27. Yao H, Ibayashi S, Nakane H, Cai H, Uchimura H, Fujishima M (1997) AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats. Brain Res 753:80-85
28. Yatsugi S, Takahashi M, Kawasaki-Yatsugi S, Koshiya K, Sakamoto S, Uematsu D, Shimizu-Sasamata M (1996) Neuroprotective effect of YM90K, a novel AMPA/Kainate receptor antagonist, in focal ischemia in cats. J Cereb Blood Flow Metab 16:959-966
29. ZeaLonga E, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 19:480-485